ID
12654
Description
Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL); ODM derived from: https://clinicaltrials.gov/show/NCT00130195
Link
https://clinicaltrials.gov/show/NCT00130195
Keywords
Versions (1)
- 08/12/2015 08/12/2015 -
Uploaded on
8 de dezembro de 2015
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Acute Lymphoblastic Leukemia NCT00130195
Eligibility Acute Lymphoblastic Leukemia NCT00130195
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
infection
Data type
boolean
Alias
- UMLS CUI [1]
- C0009450
Description
another severe and/or life-threatening disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0009488
Description
positive for hiv antibody and/or hepatitis b surface (hbs) antigen tests
Data type
boolean
Alias
- UMLS CUI [1]
- C0149709
- UMLS CUI [2]
- C0019699
Description
another primary malignancy which is clinically active
Data type
boolean
Alias
- UMLS CUI [1]
- C0006826
Description
pregnant or breastfeeding
Data type
boolean
Alias
- UMLS CUI [1]
- C0549206
- UMLS CUI [2]
- C0006147
Description
renal failure
Data type
boolean
Alias
- UMLS CUI [1]
- C1533077
Similar models
Eligibility Acute Lymphoblastic Leukemia NCT00130195
- StudyEvent: Eligibility
C1835417 (UMLS CUI [2])
C0232805 (UMLS CUI [2])
C0428772 (UMLS CUI [3])
C0019699 (UMLS CUI [2])
C0006147 (UMLS CUI [2])